[Effect of terrilytin on the concentration of antitubercular preparations in kidney tissue (experimental research)].
D000681:Amylases / Q000627:therapeutic use*; D000818:Animals; D000890:Anti-Infective Agents / Q000378:metabolism* / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D007478:Iontophoresis; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism; D010447:Peptide Hydrolases / Q000627:therapeutic use*; D011817:Rabbits; D014398:Tuberculosis, Renal / Q000188:drug therapy / Q000378:metabolism; D014464:Ultrasonic Therapy
D000890:Anti-Infective Agents; D004338:Drug Combinations; C009402:amylase, phosphates, proteases drug combinations; D000681:Amylases; D010447:Peptide Hydrolases
Vliianie terrilitina na kontsentratsiiu protivotuberkuleznykh preparatov v tkani pochki (éksperimental'noe issledovanie).